Selecta Biosciences (SELB) News Today → World’s biggest multibillionaire investor is buying THIS by the ton [picture] (From Stansberry Research) (Ad) Free SELB Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineSelb, Germany - Weather Forecasts | Maps | News - Yahoo Weatheryahoo.com - January 23 at 9:34 AMCartesian Therapeutics Inc (RNAC)investing.com - December 15 at 3:39 PMFurther weakness as Selecta Biosciences (NASDAQ:SELB) drops 17% this week, taking five-year losses to 85%finance.yahoo.com - November 14 at 7:12 AMPared-down Selecta merges with Maryland biotechbizjournals.com - November 13 at 9:09 PMSelecta Biosciences Merges With Cartesian To Focus On Autoimmune Cell Therapymsn.com - November 13 at 4:08 PMSelecta Biosciences Merges With Cartesian Therapeutics In All-stock Dealmarkets.businessinsider.com - November 13 at 8:56 AMmarketbeat.com - November 13 at 8:02 AMSHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Selecta Biosciences, Inc. (NASDAQ: SELB) and Encourages Investors to Contact the Firmbenzinga.com - November 11 at 1:58 PMSelecta Biosciences Inc SELBmorningstar.com - November 10 at 2:48 PMSelecta Biosciences in Deal to Transfer Manufacturing, Development Rights of Sel-212 Treatmentmarketwatch.com - October 31 at 5:20 PMSelecta Announces Transition of Manufacturing and Clinical Operations of ImmTOR for SEL-212 to Commercialization Partner Sobifinance.yahoo.com - October 31 at 5:20 PMSelecta Biosciences files for $200M mixed shelfmsn.com - October 25 at 6:23 PMMizuho Maintains Selecta Biosciences (SELB) Buy Recommendationmsn.com - August 19 at 12:24 PMSVB Leerink Downgrades Selecta Biosciences (SELB)msn.com - August 19 at 6:33 AMAnalyst Ratings for Selecta Biosciencesmarkets.businessinsider.com - August 18 at 8:31 PMNeedham Maintains Selecta Biosciences (SELB) Buy Recommendationmsn.com - August 18 at 8:31 PMSelecta Biosciences (SELB) Gets a Buy from H.C. Wainwrightmarkets.businessinsider.com - August 18 at 10:11 AMSelecta Biosciences (NASDAQ:SELB) Releases Quarterly Earnings Results, Beats Estimates By $0.05 EPSmarketbeat.com - August 18 at 9:33 AMSelecta Biosciences' (SELB) "Market Perform" Rating Reaffirmed at SVB Leerinkmarketbeat.com - August 18 at 8:17 AMMizuho Securities Reaffirms Their Buy Rating on Selecta Biosciences (SELB)markets.businessinsider.com - August 17 at 11:11 PMQ2 2023 Selecta Biosciences Inc Earnings Callfinance.yahoo.com - August 17 at 11:11 PMSelecta Biosciences Narrows R&D Focus On Gout Candidatemsn.com - August 17 at 6:10 PMSelecta Biosciences, Inc. (SELB) Reports Q2 Loss, Misses Revenue Estimatesfinance.yahoo.com - August 17 at 6:10 PMSelecta Biosciences Reports Second Quarter 2023 Financial Results and Updates on Strategic Initiative Designed to Maximize Stockholder Value Associated with SEL-212 Economicsfinance.yahoo.com - August 17 at 7:54 AMSelecta Biosciences, Inc.'s (NASDAQ:SELB) largest shareholders are individual investors with 35% ownership, institutions own 26%finance.yahoo.com - July 14 at 8:45 AMSelecta Biosciences (NASDAQ:SELB) Rating Lowered to Hold at StockNews.commarketbeat.com - June 9 at 1:25 AMSelecta Biosciences, Inc. (NASDAQ:SELB) Shares Sold by GSA Capital Partners LLPmarketbeat.com - June 8 at 5:58 AMConnor Clark & Lunn Investment Management Ltd. Sells 119,611 Shares of Selecta Biosciences, Inc. (NASDAQ:SELB)marketbeat.com - June 6 at 5:56 AMSelecta Biosciences (NASDAQ:SELB) shareholders are up 22% this past week, but still in the red over the last five yearsfinance.yahoo.com - June 3 at 10:28 AMSelecta Biosciences Announces Presentation of Data from Phase 3 DISSOLVE Program of SEL-212 in Chronic Refractory Gout During Late-Breaking Session at the EULAR 2023 European Congress of Rheumatologyfinance.yahoo.com - May 31 at 7:41 AMSelecta Biosciences, Inc. (NASDAQ:SELB) Receives Consensus Rating of "Moderate Buy" from Brokeragesmarketbeat.com - May 12 at 5:13 AMNewsflash: Selecta Biosciences, Inc. (NASDAQ:SELB) Analysts Have Been Trimming Their Revenue Forecastsfinance.yahoo.com - May 9 at 7:49 AMHC Wainwright & Co. Reiterates Selecta Biosciences (SELB) Buy Recommendationmsn.com - May 8 at 8:03 PMStockNews.com Downgrades Selecta Biosciences (NASDAQ:SELB) to Holdmarketbeat.com - May 5 at 10:24 PMSelecta cuts in-house gene therapy programs, lays off 15bizjournals.com - May 5 at 3:01 PMMizuho Securities Sticks to Their Buy Rating for Selecta Biosciences (SELB)markets.businessinsider.com - May 4 at 8:17 PMSelecta Biosciences, Inc. (SELB) Reports Q1 Loss, Misses Revenue Estimatesfinance.yahoo.com - May 4 at 3:16 PMSelecta Biosciences, Inc.: Selecta Biosciences Reports First Quarter 2023 Financial Results and Provides Business Updatefinanznachrichten.de - May 4 at 10:16 AMSelecta Biosciences Reports First Quarter 2023 Financial Results and Provides Business Updatefinance.yahoo.com - May 4 at 10:16 AMSelecta Biosciences to Host Conference Call and Webcast to Discuss First Quarter 2023 Financial Results and Provide Business Updatefinance.yahoo.com - April 28 at 8:21 PMInvestors Holding Back On Selecta Biosciences, Inc. (NASDAQ:SELB)finance.yahoo.com - April 18 at 10:51 AMNeedham Reiterates Selecta Biosciences (SELB) Buy Recommendationmsn.com - April 13 at 7:03 PMWhat 6 Analyst Ratings Have To Say About Selecta Biosciencesmarkets.businessinsider.com - April 13 at 2:02 PMAnalysts Offer Insights on Healthcare Companies: United Therapeutics (UTHR), Selecta Biosciences (SELB) and Denali Therapeutics (DNLI)markets.businessinsider.com - April 13 at 9:02 AMIs Selecta Biosciences, Inc.'s (NASDAQ:SELB) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?finance.yahoo.com - March 27 at 10:17 AMThe Latest Analyst Ratings for Selecta Biosciencesmarkets.businessinsider.com - March 22 at 1:57 PMMizuho Cuts Selecta Biosciences (NASDAQ:SELB) Price Target to $4.00marketbeat.com - March 22 at 7:43 AMBTIG Sticks to Their Buy Rating for Selecta Biosciences (SELB)markets.businessinsider.com - March 22 at 12:26 AMSelecta, SOBI's Chronic Refractory Gout Program Meets Primary Goal, US Submission Expected Next Yearfinance.yahoo.com - March 21 at 2:25 PMSelecta surges ~20% as gout drug SEL-212 meets main goal in 2 phase 3 trialsmsn.com - March 21 at 9:25 AM Get Selecta Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SELB and its competitors with MarketBeat's FREE daily newsletter. Email Address top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall. Click here now for the full details of this stock that’s set to rocket in the AI revolution… SELB Media Mentions By Week SELB Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SELB News Sentiment▼0.000.41▲Average Medical News Sentiment SELB News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SELB Articles This Week▼01▲SELB Articles Average Week Get Selecta Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SELB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: NGM Biopharmaceuticals News Today Syros Pharmaceuticals News Today CytomX Therapeutics News Today Vistagen Therapeutics News Today Kinnate Biopharma News Today ProQR Therapeutics News Today Theseus Pharmaceuticals News Today Assembly Biosciences News Today Immutep News Today vTv Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SELB) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyYour Money is Not SafeAmerican AlternativeThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Selecta Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
